Drug Type Small molecule drug |
Synonyms CH 7057288, CH7057288 |
Target |
Action antagonists, inhibitors |
Mechanism TrkA antagonists(Nerve growth factor receptor Trk-A antagonists), TrkB inhibitors(Neurotrophic tyrosine kinase receptor type 2 inhibitors), TrkC inhibitors(Neurotrophic tyrosine kinase receptor type 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H31N3O5S |
InChIKeyDCGOHGQJHJXBGW-UHFFFAOYSA-N |
CAS Registry2095616-82-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | Japan | - | |
Lung Cancer | Preclinical | Japan | - |